Post hoc analysis revealed significantly higher MMSE scores in AD patients carrying higher levels of natural anti-NMDAR1 autoantibodies than in AD patients carrying lower levels of natural anti-NMDAR1 autoantibodies (Welch’s t-test, t= 2.9848, p=0.003583). This evidence concerns the gene GRIN1 and Alzheimer disease.